retatrutide safety Weight Loss Truth Unapproved weight-loss drug "reta" sold

Most respond well to dose escalation or behavioral intervention

People with diabetes Diabetes independently increases UTI risk through multiple mechanisms

It is called a triple agonist because it targets GLP-1, GIP, and glucagon receptors

GLP-1 medications can affect how much and how often you eat

The patient population is very large, so when you start seeing these types of possible complications or adverse events, they need to be looked at, and theyll likely be added to labeling, Russo added, reiterating that it does not mean that the drugs are unsafe

In the diabetes trial, retatrutide decreased plasma triglyceride by up to 35% at 36 weeks compared with 4% reduction with dulaglutide and 9% with placebo [4]